Synopsys, Inc.
SNPSLast close · Oct 16, 2026454.63−13.48 (−2.88%)
Market cap$87.1B
11 firms' latest targets, last 90 days: median $570.00 ($420.00–$700.00), 25% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-12 | Needham | $620.00 | ▲ 7% | +36% |
| 2026-10-01 | Deutsche Bank | $640.00 | — | +41% |
| 2026-10-01 | KeyBanc | $605.00 | ▲ 1% | +33% |
| 2026-10-01 | Wells Fargo | $540.00 | ▲ 14% | +19% |
| 2026-09-25 | HSBC | $700.00 | ▲ 54% | +54% |
| 2026-09-24 | BNP Paribas Exane | $420.00 | — | -8% |
| 2026-08-27 | UBS | $570.00 | — | +25% |
| 2026-08-27 | Mizuho Securities | $550.00 | — | +21% |
| 2026-08-27 | Baird | $560.00 | = 0% | +23% |
| 2026-08-25 | Rosenblatt Securities | $575.00 | — | +26% |
| 2026-08-19 | Morgan Stanley | $500.00 | ▼ 5% | +10% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $5.8B | +15% | $7.92 | +26% | est. $5.8B+0% | est. $11.09 | 10 |
| 2024reported | $6.1B | +5% | $14.51 | +83% | est. $6.1B+0% | est. $13.12 | 22 |
| 2025reported | $7.1B | +15% | $8.04 | -45% | est. $7.0B+0% | est. $12.83 | 16 |
| 2026 | $9.7B | +38% | $15.14 | +18% | $9.7B–$9.7B | $15.04–$15.18 | 17 |
| 2027 | $11.0B | +13% | $18.66 | +23% | $11.0B–$11.0B | $17.37–$19.61 | 14 |
| 2028 | $12.5B | +14% | $22.89 | +23% | $11.8B–$13.0B | $15.11–$34.17 | 19 |
| 2029 | $14.3B | +14% | $27.38 | +20% | $14.1B–$14.5B | $26.69–$27.77 | 18 |
| 2030 | $16.3B | +14% | $33.51 | +22% | $16.0B–$16.5B | $32.67–$33.98 | 9 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.